PathoGenetix Raises $4M in First Close of Series B

The company, once called US Genomics, will use the funds to complete development of its first commercial systems for identifying pathogens in complex biological samples.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories